PLK1 and colorectal cancer: However, Several PLK1 inhibitors targeting breast and colorectal cancers have entered clinical trials recently but have demonstrated weak antitumor capacity against solid tumors [31], and few studies have focused on the therapeutic role of PLK1 in LA.